Biodetection MarketSize and Trends

Biodetection Market Outlook - Increasing Cross-border Wars Leading to Growing Concern About Bio-contaminants

Regulatory policies and safety standards govern global biodetection market growth. Geographically, Europe and North America are the major revenue contributors to the global biodetection market, as these regions make major investments in bio-surveillance systems and ensure implementation of highly efficient technologies and systems. On the other hand, Asia Pacific and Rest of the World provides lucrative opportunities for biodetection systems, as the governments in these regions are trying to prevent bio attacks and implement effective methods for minimizing damage caused by these attacks.

Steady rise in use of biological agents and weapons along with increased awareness of bioterrorism and biological warfare, is fueling demand for biodetection, especially in Asia Pacific and Middle East regions. Biodetection technologies and medications against potential biological agents and extensive support from governments across the globe is projected to further propel growth of biodetection market. On the contrary, challenges in identification of minute pathogens and increasing misuse of scientific technologies along with increasing circulation of harmful biological weapons and agents would impede biodetection market growth. Some of the companies operating in the global biodetection market include Agilent Technologies, Smiths Group plc, Cepheid, Inc., Roche Diagnostics, Dycor Technologies, Ltd., and BioDetection Systems B.V.

Biodetection Market Taxonomy

On the basis of type of product and services, the global biodetection market is classified into:

Product Type

Bioanalyses
Instruments
Reagents and Media
Accessories and Consumables

Services

Bioanalyses
Chemical analyses
DNA based assays

On the basis of application, the global biodetection market is classified into:

Defense
Food and Environment
Clinical

DNA-based analyses are highly sensitive and validate the presence or absence of a specific species in a sample and assess the presence or absence of specific type of genes in a genome. These analyses are carried out by employing gene sequencing processes along with other molecular diagnostic techniques. Chemical analyses aid in detection and determination of complex mixture of bioactive compounds present in sample (clinical, food or environmental origin). These analyses involve the implementation of several chemical analytical fractionation techniques such as solid phase extraction (SPE), high performance liquid chromatography (HPLC), and gel permeation chromatography. Laboratories involved in offering these services are as per the approved calibration standards and respective government guidelines.